Assessment of the change of antiemetic prophylaxis from double to triple combination in patients with high dose carboplatin chemotherapy.

Autor: Albanell-Fernández M; Pharmacy Department, Division of Medicines, Hospital Clinic of Barcelona, Barcelona, Spain., Pérez Sánchez Á; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Monge-Escartín I; Pharmacy Department, Division of Medicines, Hospital Clinic of Barcelona, Barcelona, Spain., Riu-Viladoms G; Pharmacy Department, Division of Medicines, Hospital Clinic of Barcelona, Barcelona, Spain., Rodríguez Mues MC; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Corominas Bosch ML; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Gaba García L; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Rollán NB; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Reguart N; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Soy Muner D; Pharmacy Department, Division of Medicines, Hospital Clinic of Barcelona, Barcelona, Spain.; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Pharmacology, Toxicology and Therapeutic Chemistry, School of Pharmacy, University of Barcelona, Barcelona, Spain., Carcelero San Martín E; Pharmacy Department, Division of Medicines, Hospital Clinic of Barcelona, Barcelona, Spain.

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Sep; Vol. 30 (6), pp. 999-1009. Date of Electronic Publication: 2023 Aug 10.